Skip to main content
logo
Telescope Innovations Corp. (CSE:TELI)
Canada flag Canada · Delayed Price · Currency is CAD
0.3550
+0.0150 (4.41%)
Aug 1, 2025, 1:54 PM EDT

CTI BioPharma Income Statement

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Aug '24 Aug '23 Aug '22 Aug '21 Aug '20
Operating Revenue
3.974.272.820.6--
Other Revenue
0.640.16----
Revenue
4.624.432.820.6--
Revenue Growth (YoY)
18.37%56.80%374.31%---
Cost of Revenue
---0.930.02-
Gross Profit
4.624.432.82-0.33-0.02-
Selling, General & Admin
5.043.792.942.250.690.03
Research & Development
---0.060.130.2
Other Operating Expenses
0.440.710.03---
Operating Expenses
6.545.43.475.330.870.23
Operating Income
-1.93-0.97-0.64-5.67-0.89-0.23
Interest Expense
-0.21-0.24----
Currency Exchange Gain (Loss)
-0.16-0.0400.01-0-
Other Non Operating Income (Expenses)
-0.06-0.08-0.08-0.09-0.01-
EBT Excluding Unusual Items
-2.36-1.32-0.72-5.75-0.89-0.23
Other Unusual Items
-----3.13-
Pretax Income
-2.36-1.32-0.72-5.75-4.03-0.23
Net Income
-2.36-1.32-0.72-5.75-4.03-0.23
Net Income to Common
-2.36-1.32-0.72-5.75-4.03-0.23
Shares Outstanding (Basic)
5454534826-
Shares Outstanding (Diluted)
5454534826-
Shares Change (YoY)
-1.23%1.80%8.86%87.06%--
EPS (Basic)
-0.04-0.02-0.01-0.12-0.16-
EPS (Diluted)
-0.04-0.02-0.01-0.12-0.16-
Free Cash Flow
0.23-0.02-1.79-2.57-1.54-0.2
Free Cash Flow Per Share
0.00--0.03-0.05-0.06-
Gross Margin
100.00%100.00%100.00%-56.22%--
Operating Margin
-41.74%-21.93%-22.73%-951.83%--
Profit Margin
-51.04%-29.89%-25.43%-965.24%--
Free Cash Flow Margin
5.01%-0.45%-63.48%-432.47%--
EBITDA
-1.41-0.6-0.34-5.39--
EBITDA Margin
-30.55%-13.56%-11.98%---
D&A For EBITDA
0.520.370.30.28--
EBIT
-1.93-0.97-0.64-5.67-0.89-0.23
EBIT Margin
-41.74%-21.93%-22.73%---
Revenue as Reported
4.624.432.82---
Advertising Expenses
-0.080.080.010-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.